Federal Officials, Researchers, Clinicians and Biopharma Leadership Convened by Psychedelic Medicine Coalition at the National Press Club Vancouver, Canada, May...
MORRISVILLE, N.C., May 14, 2026 (GLOBE NEWSWIRE) -- Syneos Health® today announced new and expanded strategic partnerships that strengthen its...
First-of-its-kind partnership expands NeuroStar platform capabilities with advanced visualization technology designed to address evolving provider needs and support more personalized...
BOCA RATON, FL, May 14, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB), a late-stage biotechnology company focused on...
Debra Hussain brings over 25 years of deep expertise in implementing commercial excellence and driving the launch of products and...
US Under Secretary of Commerce Jeffrey Kessler, Texas State Senator Brent Hagenbuch, Novartis leadership mark expansion of company’s coast-to-coast RLT...
US Under Secretary of Commerce Jeffrey Kessler, Texas State Senator Brent Hagenbuch, Novartis leadership mark expansion of company’s coast-to-coast RLT...
Teva exceeded all sustainability-linked bond targets, linking financial performance to expanded patient access to medicines and reduced environmental impact.Through its...
Doheny scientists, clinician-scientists, and research fellows will present findings on eye disease, advanced imaging, artificial intelligence and more at the...
BURLINGTON, Mass. and JERUSALEM, April 29, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...
For an accessible version of this Press Release, please visit www.tevapharm.com Q1 2026 revenues of ~$4.0 billion increased by 2%...
Ecopipam, Emalex’s investigational asset for pediatric Tourette syndrome (TS), is a first-in-class selective dopamine D1 receptor antagonist with FDA Orphan...
A $500 million commitment — and a call for the global scientific community to join — aims to unlock predictive...
NEW YORK, NY / ACCESS Newswire / April 23, 2026 / Protagenic Therapeutics, Inc. (OTCQB:PTIX), a clinical-stage biopharmaceutical company pioneering...
CALGARY, Alberta, April 23, 2026 (GLOBE NEWSWIRE) -- Marvel Biosciences Corp. (TSXV: MRVL | OTC: MBCOF), and its wholly-owned subsidiary,...
Addition of globally recognized leaders in translational science and clinical development as the Company advances its pipeline towards key inflection...
AUBURN, Ala., April 22, 2026 /PRNewswire/ -- As Artificial Intelligence (AI) becomes more integrated into daily life, Auburn University's College...
COLORADO SPRINGS, Colo., April 22, 2026 /PRNewswire/ -- IntraNerve Neuroscience, a national provider of remote Continuous EEG (cEEG) monitoring services,...
In this free webinar, see how AI can deliver practical value across the CNS trial journey today in eCOA, imaging...
The new program joins 24+ conditions plus medication support in one platform, giving health plans and employers a single solution...